Killer Cell Immunoglobulin-like Receptor Variants Are Associated with Protection from Symptoms Associated with More Severe Course in Parkinson Disease.


Journal

Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R

Informations de publication

Date de publication:
01 09 2020
Historique:
received: 07 02 2020
accepted: 28 06 2020
pubmed: 28 7 2020
medline: 23 3 2021
entrez: 26 7 2020
Statut: ppublish

Résumé

Immune dysfunction plays a role in the development of Parkinson disease (PD). NK cells regulate immune functions and are modulated by killer cell immunoglobulin-like receptors (KIR). KIR are expressed on the surface of NK cells and interact with HLA class I ligands on the surface of all nucleated cells. We investigated

Identifiants

pubmed: 32709660
pii: jimmunol.2000144
doi: 10.4049/jimmunol.2000144
pmc: PMC7484130
mid: NIHMS1609167
doi:

Substances chimiques

HLA-B Antigens 0
HLA-Bw4 antigen 0
KIR3DL1 protein, human 0
Ligands 0
Receptors, KIR3DL1 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1323-1330

Subventions

Organisme : NIAID NIH HHS
ID : U01 AI090905
Pays : United States
Organisme : NINDS NIH HHS
ID : U19 NS095774
Pays : United States

Informations de copyright

Copyright © 2020 by The American Association of Immunologists, Inc.

Références

Br J Dermatol. 2016 Feb;174(2):449-51
pubmed: 26286807
Hum Mol Genet. 1997;6(10):1687-91
pubmed: 9300660
J Exp Med. 1995 Mar 1;181(3):1133-44
pubmed: 7532677
J Alzheimers Dis. 2019;67(4):1379-1389
pubmed: 30689576
Int J Immunogenet. 2013 Feb;40(1):39-45
pubmed: 23280119
Acta Neuropathol. 2019 May;137(5):825-836
pubmed: 30805666
Ann Neurol. 1985 Apr;17(4):329-33
pubmed: 4004153
Sci Immunol. 2018 Nov 9;3(29):
pubmed: 30413420
Hum Immunol. 2015 Aug;76(8):565-70
pubmed: 26187163
J Neurol. 2009 Feb;256(2):256-63
pubmed: 19219572
Blood. 2009 Dec 10;114(25):5182-90
pubmed: 19828694
J Immunol. 2008 May 15;180(10):6743-50
pubmed: 18453594
Mov Disord. 2015 Feb;30(2):266-9
pubmed: 25447933
Hum Genet. 2015 Sep;134(9):929-40
pubmed: 26099314
Nat Genet. 2010 Sep;42(9):781-5
pubmed: 20711177
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Neurol Sci. 2017 Aug;38(8):1373-1380
pubmed: 28497309
Psychol Med. 2009 Nov;39(11):1907-11
pubmed: 19335933
Curr Top Microbiol Immunol. 2006;298:175-82
pubmed: 16323416
J Immunol. 2005 Oct 15;175(8):5222-9
pubmed: 16210627
Immunol Today. 1984 Jul;5(7):193-4
pubmed: 25289953
J Exp Med. 2006 Mar 20;203(3):633-45
pubmed: 16533882
Neurology. 2016 Apr 12;86(15):1400-1407
pubmed: 26865518
Hum Mutat. 2008 Feb;29(2):315-22
pubmed: 17994548
Proc Natl Acad Sci U S A. 2019 Apr 9;116(15):7419-7424
pubmed: 30910980
Arch Neurol. 1985 Dec;42(12):1132-3
pubmed: 4062609
Eur J Immunol. 1996 Aug;26(8):1974-7
pubmed: 8765048
Immunogenetics. 2009 Oct;61(10):663-71
pubmed: 19789864
Genes Immun. 2016 Apr;17(3):199-202
pubmed: 26866467
Neurology. 1998 May;50(5):1346-50
pubmed: 9595985
J Neuroimmunol. 2014 Apr 15;269(1-2):52-5
pubmed: 24529855
Parkinsonism Relat Disord. 2008;14(1):46-51
pubmed: 17702627
Science. 1996 Nov 15;274(5290):1197-9
pubmed: 8895469
Neurology. 1990 Oct;40(10):1529-34
pubmed: 2215943
Database (Oxford). 2013 Apr 12;2013:bat021
pubmed: 23584834
J Comput Chem. 2005 Dec;26(16):1781-802
pubmed: 16222654
Bioinformatics. 2006 Nov 1;22(21):2695-6
pubmed: 16940322
Ann Neurol. 2016 Oct;80(4):499-510
pubmed: 27464262
Immunol Rev. 2015 Sep;267(1):259-82
pubmed: 26284483
J Neuroimmunol. 2003 Dec;145(1-2):103-14
pubmed: 14644036
Nature. 2017 Jun 29;546(7660):656-661
pubmed: 28636593
EMBO Rep. 2009 Oct;10(10):1103-10
pubmed: 19730434
Stat Med. 1990 Jul;9(7):811-8
pubmed: 2218183
Sci Signal. 2019 Dec 17;12(612):
pubmed: 31848320
Neurology. 1994 Jul;44(7):1215-20
pubmed: 8035918
J Exp Med. 1994 Oct 1;180(4):1235-42
pubmed: 7931060
Am J Hum Genet. 2016 Aug 4;99(2):375-91
pubmed: 27486779
Neurol Sci. 2002 Sep;23 Suppl 2:S77-8
pubmed: 12548352
J Exp Med. 2016 May 2;213(5):791-807
pubmed: 27045007
Mol Immunol. 2011 Sep;48(15-16):1896-902
pubmed: 21665278
Neurology. 2013 Apr 16;80(16):1476-84
pubmed: 23516323
Immunity. 2006 Aug;25(2):331-42
pubmed: 16901727
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3053-8
pubmed: 18287063
Cell Rep. 2018 Sep 25;24(13):3367-3373.e4
pubmed: 30257198
Neurology. 1985 Apr;35(4):522-6
pubmed: 3982637
Curr Opin Immunol. 2018 Feb;50:102-111
pubmed: 29413815
Am J Pathol. 1998 Apr;152(4):879-84
pubmed: 9546347
J Immunol. 2001 Mar 1;166(5):2992-3001
pubmed: 11207248
Semin Immunol. 2006 Jun;18(3):151-8
pubmed: 16730454
J Immunol. 2016 Apr 15;196(8):3398-410
pubmed: 26962229
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11636-11647
pubmed: 32404419
Front Immunol. 2016 Jun 14;7:235
pubmed: 27379097
J Immunol. 2019 Sep 15;203(6):1629-1635
pubmed: 31405953
Arthritis Res Ther. 2006;8(4):R101
pubmed: 16805919
Immunol Rev. 2002 Dec;190:40-52
pubmed: 12493005
Nat Rev Immunol. 2013 Feb;13(2):133-44
pubmed: 23334245
Ann Neurol. 2002 Sep;52(3):276-84
pubmed: 12205639
Immunogenetics. 2012 Oct;64(10):719-37
pubmed: 22752190
Front Immunol. 2019 Jan 29;10:61
pubmed: 30761133
Innate Immun. 2011 Apr;17(2):152-63
pubmed: 20418255
Nat Genet. 2007 Jun;39(6):733-40
pubmed: 17496894
Ann Clin Transl Neurol. 2016 May 11;3(6):473-7
pubmed: 27547776
PLoS Pathog. 2008 Feb 8;4(2):e27
pubmed: 18266470
Mamm Genome. 1999 Feb;10(2):154-60
pubmed: 9922396
Mov Disord. 2013 May;28(5):668-70
pubmed: 23408503

Auteurs

Kirsten M Anderson (KM)

Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA 94158.

Danillo G Augusto (DG)

Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA 94158.

Ravi Dandekar (R)

Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA 94158.

Hengameh Shams (H)

Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA 94158.

Chao Zhao (C)

Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA 94158.

Tasneem Yusufali (T)

Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA 94158.

Gonzalo Montero-Martín (G)

Department of Pathology, Stanford University School of Medicine, Palo Alto, CA 94304.

Wesley M Marin (WM)

Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA 94158.

Neda Nemat-Gorgani (N)

Department of Structural Biology and Immunology, Stanford University, Palo Alto, CA 94305.

Lisa E Creary (LE)

Department of Pathology, Stanford University School of Medicine, Palo Alto, CA 94304.

Stacy Caillier (S)

Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA 94158.

Mohammad R K Mofrad (MRK)

Molecular Cell Biomechanics Laboratory, Department of Bioengineering and Mechanical Engineering, University of California, Berkeley, CA 94720; and.

Peter Parham (P)

Department of Structural Biology and Immunology, Stanford University, Palo Alto, CA 94305.

Marcelo Fernández-Viña (M)

Department of Pathology, Stanford University School of Medicine, Palo Alto, CA 94304.

Jorge R Oksenberg (JR)

Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA 94158.

Paul J Norman (PJ)

Division of Biomedical Informatics and Personalized Medicine, Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.

Jill A Hollenbach (JA)

Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA 94158; jill.hollenbach@ucsf.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH